Aggregatibacter actinomycetemcomitans Dispersin B: The Quintessential Antibiofilm Enzyme
Pathogens · 07.08.2024 · 13 (8) · 668
DOI: 10.3390/pathogens13080668 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 07.08.2024. Verfasst von Jeffrey B Kaplan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Skin Research, Institute for Medical Research, Galilee Medical Center, Nahariya 2210001, Israel. Hauptthemen laut MEDLINE: Aggregatibacter actinomycetemcomitans, Bacterial Proteins, Biofilms, Glycoside Hydrolases. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Health Corporation of the Galilee Medical Center, Kane Biotech, Inc..
Abstract (Originalsprache)
The extracellular matrix of most bacterial biofilms contains polysaccharides, proteins, and nucleic acids. These biopolymers have been shown to mediate fundamental biofilm-related phenotypes including surface attachment, intercellular adhesion, and biocide resistance. Enzymes that degrade polymeric biofilm matrix components, including glycoside hydrolases, proteases, and nucleases, are useful tools for studying the structure and function of biofilm matrix components and are also being investigated as potential antibiofilm agents for clinical use. Dispersin B is a well-studied, broad-spectrum antibiofilm glycoside hydrolase produced by Aggregatibacter actinomycetemcomitans. Dispersin B degrades poly-N-acetylglucosamine, a biofilm matrix polysaccharide that mediates biofilm formation, stress tolerance, and biocide resistance in numerous Gram-negative and Gram-positive pathogens. Dispersin B has been shown to inhibit biofilm and pellicle formation; detach preformed biofilms; disaggregate bacterial flocs; sensitize preformed biofilms to detachment by enzymes, detergents, and metal chelators; and sensitize preformed biofilms to killing by antiseptics, antibiotics, bacteriophages, macrophages, and predatory bacteria. This review summarizes the results of nearly 100 in vitro and in vivo studies that have been carried out on dispersin B since its discovery 20 years ago. These include investigations into the biological function of the enzyme, its structure and mechanism of action, and its in vitro and in vivo antibiofilm activities against numerous bacterial species. Also discussed are potential clinical applications of dispersin B.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory for Skin Research, Institute for Medical Research, Galilee Medical Center, Nahariya 2210001, Israel.
- Department of Materials Science and Engineering, Texas A&M University, College Station, TX 77843, USA.
- Kane Biotech Inc., Winnipeg, MB R3T 6G2, Canada.
- The Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, Israel.
- Department of Oral Biology, Rutgers School of Dental Medicine, Newark, NJ 07103, USA.
ORCID-Profile: Svetlana A Sukhishvili
Förderung
- NIGMS NIH HHS
- Health Corporation of the Galilee Medical Center
- Kane Biotech, Inc.
Zitieren
APA
Kaplan, J. B., Sukhishvili, S. A., Sailer, M., Kridin, K., & Ramasubbu, N. (2024). Aggregatibacter actinomycetemcomitans Dispersin B: The Quintessential Antibiofilm Enzyme. Pathogens, 13(8), 668. https://doi.org/10.3390/pathogens13080668
Vancouver
Kaplan JB, Sukhishvili SA, Sailer M, Kridin K, Ramasubbu N. Aggregatibacter actinomycetemcomitans Dispersin B: The Quintessential Antibiofilm Enzyme. Pathogens. 2024;13(8):668. doi:10.3390/pathogens13080668
BibTeX
@article{Kaplan2024,
author = {Kaplan, Jeffrey B and Sukhishvili, Svetlana A and Sailer, Miloslav and Kridin, Khalaf and Ramasubbu, Narayanan},
title = {Aggregatibacter actinomycetemcomitans Dispersin B: The Quintessential Antibiofilm Enzyme},
journal = {Pathogens},
year = {2024},
volume = {13},
number = {8},
pages = {668},
doi = {10.3390/pathogens13080668}
}
EUVIMED